Market Cap
₹1,233 Cr.
P/E
13.22
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
14.51%
3yr Average
15.84%
5yr Average
16.41%
Net Profit Margin
Latest
14.29%
3yr Average
14.55%
5yr Average
14.05%
ROCE
Latest
18.97%
3yr Average
20.88%
5yr Average
20.86%
Debt to Equity
Latest
0.0
3yr Average
0.0
5yr Average
0.03
Market Share
0.04% (as of Jul 22)
Anti - Diabetes - Market Share
0.15% (as of Jul 22)
Anti-Infectives - Market Share
0.80% (as of Nov 21)
Anti-Malarial - Market Share
0.10% (as of Nov 21)
Blood Related - Market Share
0.02% (as of Jul 22)
Cardiovascular - Market Share
0.11% (as of Nov 21)
Dermatology - Market Share
0.02% (as of Nov 21)
Endocrinology - Market Share
0.12% (as of Jul 22)
Gastro-Intestinal - Market Share
0.19% (as of Nov 21)
Gynecology - Market Share
0.01% (as of Feb 21)
Neurological - Market Share
0.01% (as of Jul 21)
Ophthalmology - Market Share
0.23% (as of Nov 21)
Pain - Market Share
0.11% (as of Jul 22)
Pharmaceutical Sector - Market Share
0.36% (as of Nov 21)
Respiratory - Market Share
0.11% (as of Nov 21)
Stomatological - Market Share
0.01% (as of Nov 21)
Urology - Market Share
0.10% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis